Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Noail F Isho"'
Autor:
Tanner B. Pollock, Giovan N. Cholico, Noail F. Isho, Ryan J. Day, Tarun Suresh, Erica S. Stewart, Madyson M. McCarthy, Troy T. Rohn
Publikováno v:
Frontiers in Aging Neuroscience, Vol 12 (2020)
Despite the fact that harboring the apolipoprotein E4 (APOE4) allele represents the single greatest risk factor for late-onset Alzheimer’s disease (AD), the exact mechanism by which ApoE4 contributes to disease progression remains unknown. Recently
Externí odkaz:
https://doaj.org/article/e95f6b20d7194a5fbf7ce14c717b882b
Autor:
Tanya Sanghal, Troy T. Rohn, Stephanie J. Galla, Tanner B Pollock, Eric J. Hayden, Tarun Suresh, Noail F Isho, Arni Kulkarni, James D. Beck
Publikováno v:
Int J Neurodegener Dis
The apolipoprotein E4 (APOE4) allele represents the single greatest risk factor for late-onset Alzheimer's disease (AD) and accumulating evidence suggests that fragmentation with a toxic-gain of function may be a key molecular step associated with th
Autor:
Troy T. Rohn, Tarun Suresh, Erica S. Stewart, Tanner B Pollock, Madyson M McCarthy, Ryan Day, Giovan N. Cholico, Noail F Isho
Publikováno v:
Frontiers in Aging Neuroscience
Frontiers in Aging Neuroscience, Vol 12 (2020)
Frontiers in Aging Neuroscience, Vol 12 (2020)
Despite the fact that harboring the apolipoprotein E4 (APOE4) allele represents the single greatest risk factor for late-onset Alzheimer’s disease (AD), the exact mechanism by which ApoE4 contributes to disease progression remains unknown. Recently
Autor:
Ryan Day, Alexandra E. Oxford, Raquel J. Brown, Eric J. Hayden, Jacob M Mack, Brad E. Morrison, Noail F Isho, Troy T. Rohn, Tanner B Pollock
Publikováno v:
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Vol 2019 (2019)
Oxidative Medicine and Cellular Longevity, Vol 2019 (2019)
Despite the fact that harboring the apolipoprotein E4 (APOE4) allele represents the single greatest risk factor for late-onset Alzheimer’s disease (AD), the exact mechanism by which apoE4 contributes to disease progression remains unknown. Recently
Publikováno v:
Journal of Alzheimer's disease & Parkinsonism
Despite a wealth of knowledge gained in the past three decades concerning the molecular underpinnings of Alzheimer's disease (AD), progress towards obtaining effective, disease modifying therapies has proven to be challenging. In this manner, numerou